Sign In
Buy AQSZF
$0.0011
+0 (+0%)
At Close: Jun 23, 2026
Aequus Announces Completion of Previously Announced Sale of ZIMED(R) PF
12:40pm, Tuesday, 31'st Mar 2026
VANCOUVER, British Columbia – TheNewswire - March 31, 2026 – Aequus Pharmaceuticals Inc. (TSX-V: AQS) (“ Aequus ” or the “ Company ”), a specialty pharmaceutical company, today announced t
Aequus Provides Additional Disclosure in Connection with Annual General and Special Meeting of Shareholders
04:00pm, Thursday, 13'th Nov 2025
VANCOUVER, November 13th, 2025 – TheNewswire - Aequus Pharmaceuticals Inc. (TSX-V: AQS) (“Aequus” or the “Company”) wishes to provide certain additional information in connection with the Co
Aequus Provides Additional Disclosure in Connection with Annual General and Special Meeting of Shareholders
05:00pm, Wednesday, 12'th Nov 2025
VANCOUVER, November 12, 2025 – TheNewswire - Aequus Pharmaceuticals Inc. (TSX-V: AQS) (“Aequus” or the “Company”) wishes to provide certain additional information in connection with the Comp
Aequus Announces Giovanni Di Genova Joining Board of Directors
04:40pm, Monday, 22'nd Sep 2025
VANCOUVER, September 22 nd , 2025 – TheNewswire - Aequus Pharmaceuticals Inc. (TSX-V: AQS) (“Aequus” or the “Company”), a specialty pharmaceutical company focused on bringing healthcare solu
Aequus Reports First Quarter 2025 Financial Highlights
09:51pm, Wednesday, 21'st May 2025
VANCOUVER – TheNewswire - May 21 st , 2025 – Aequus Pharmaceuticals Inc. (TSX-V: AQS) (“Aequus” or the “Company”), a specialty pharmaceutical company focused on bringing healthcare solutio
Aequus Reports Second Quarter 2023 Financial Highlights and General Update
09:53pm, Tuesday, 29'th Aug 2023
VANCOUVER, British Columbia, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a foc
Aequus Announces Zimed PF Now Available in Canada
08:00am, Thursday, 24'th Aug 2023
VANCOUVER, British Columbia, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), ) (“Aequus” or the “Company”), a specialty pharmaceutical company announc
Aequus Announces Zimed PF Website Launch
08:00am, Tuesday, 22'nd Aug 2023
VANCOUVER, British Columbia, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), ) (“Aequus” or the “Company”), a specialty pharmaceutical company, are th
Aequus Pharmaceutical Canada Announces a Pause in Sales of Evolve Intensive Eyedrops and Gel in Canada
08:00am, Friday, 18'th Aug 2023
VANCOUVER, British Columbia, Aug. 18, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), ) (“Aequus” or the “Company”), a specialty pharmaceutical company announc
Aequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%)
07:21pm, Thursday, 06'th Jul 2023
VANCOUVER, British Columbia, July 06, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), announces today it has increased its debt by
Aequus Pharmaceuticals achieves its second-highest quarterly revenue to date
09:33am, Monday, 30'th Aug 2021
Aequus Pharmaceuticals Inc. reports that it achieved its second-highest quarterly revenue to date.
Aequus Reports Second Quarter 2021 Financial Highlights
08:00am, Monday, 30'th Aug 2021
Second Highest Quarterly Revenues in Company History Second Highest Quarterly Revenues in Company History
Aequus Pharmaceuticals appoints Dr. Robert Koenekoop as its consultant on inherited retinal diseases
09:38am, Wednesday, 25'th Aug 2021
Aequus Pharmaceuticals Inc said Dr. Robert Koenekoop has joined the company as a medical and clinical consultant on inherited retinal diseases, and specifically to support Aequus' previously-annou
Aequus Pharmaceuticals and reVision Therapeutics in collaboration to develop therapy for Stargardt disease
09:58am, Tuesday, 17'th Aug 2021
Aequus Pharmaceuticals Inc. and reVision Therapeutics, Inc.
Aequus Pharmaceuticals bringing diverse pipeline of new drugs to the Canadian market
10:20am, Friday, 02'nd Jul 2021
Focused on developing and commercializing high-quality products Pipeline includes several commercial products in ophthalmology and transplant Also has a development stage pipeline in neurology What�
